A to Z / Metabolic / weight loss
Dulaglutide
Also known as Trulicity.
Best known for The weekly GLP-1 for diabetes, not weight loss
Evidence★★★★★
Safety dataWell characterised
Route Weekly injection
United StatesFDA approved (type 2 diabetes)
AustraliaSchedule 4: ARTG-registered
as at 16 September 2026
What it is
Dulaglutide is a long-acting GLP-1 receptor agonist, an approved medicine for type 2 diabetes available as Trulicity. It is a GLP-1 molecule fused to an antibody fragment, which is what gives it a weekly dosing interval.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Semaglutide, Liraglutide, Exenatide, Tirzepatide
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Dulaglutide. It is not medical advice and not a recommendation to use it.